|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007222,
umls-concept:C0008976,
umls-concept:C0016410,
umls-concept:C0022671,
umls-concept:C0040732,
umls-concept:C0205225,
umls-concept:C0301630,
umls-concept:C0376387,
umls-concept:C0679250,
umls-concept:C1274040,
umls-concept:C1801960
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2011-4-26
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Kidney transplant recipients, like other patients with chronic kidney disease, experience excess risk of cardiovascular disease and elevated total homocysteine concentrations. Observational studies of patients with chronic kidney disease suggest increased homocysteine is a risk factor for cardiovascular disease. The impact of lowering total homocysteine levels in kidney transplant recipients is unknown.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:BostomAndrew GAG,
pubmed-author:CarpenterMyra AMA,
pubmed-author:ColeEdwardE,
pubmed-author:Gravens-MuellerLisaL,
pubmed-author:HouseAndrew AAA,
pubmed-author:HunsickerLawrenceL,
pubmed-author:JacquesPaul FPF,
pubmed-author:KewCliftonC,
pubmed-author:KusekJohn WJW,
pubmed-author:LeveyAndrew SAS,
pubmed-author:McKenneyJoyce LJL,
pubmed-author:Pacheco-SilvaAlvaroA,
pubmed-author:PesaventoToddT,
pubmed-author:PfefferMarc AMA,
pubmed-author:PirschJohnJ,
pubmed-author:SelhubJacobJ,
pubmed-author:SmithStephenS,
pubmed-author:SolomonScottS,
pubmed-author:WeirMatthewM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
26
|
|
pubmed:volume |
123
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1763-70
|
|
pubmed:dateRevised |
2011-7-20
|
|
pubmed:meshHeading |
pubmed-meshheading:21482964-Adult,
pubmed-meshheading:21482964-Aged,
pubmed-meshheading:21482964-Arteriosclerosis,
pubmed-meshheading:21482964-Cardiovascular Diseases,
pubmed-meshheading:21482964-Death, Sudden, Cardiac,
pubmed-meshheading:21482964-Female,
pubmed-meshheading:21482964-Folic Acid,
pubmed-meshheading:21482964-Follow-Up Studies,
pubmed-meshheading:21482964-Humans,
pubmed-meshheading:21482964-Hyperhomocysteinemia,
pubmed-meshheading:21482964-Kaplan-Meier Estimate,
pubmed-meshheading:21482964-Kidney Failure, Chronic,
pubmed-meshheading:21482964-Kidney Transplantation,
pubmed-meshheading:21482964-Male,
pubmed-meshheading:21482964-Middle Aged,
pubmed-meshheading:21482964-Myocardial Infarction,
pubmed-meshheading:21482964-Risk Factors,
pubmed-meshheading:21482964-Risk Reduction Behavior,
pubmed-meshheading:21482964-Stroke,
pubmed-meshheading:21482964-Vitamin B Complex
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
|
|
pubmed:affiliation |
Rhode Island Hospital, 110 Lockwood Street, Providence, RI 02903, USA. abostom@lifespan.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|
